Medtronic plc (MDT)
| Market Cap | 105.23B |
| Revenue (ttm) | 32.32B |
| Net Income (ttm) | 4.20B |
| Shares Out | 1.33B |
| EPS (ttm) | 3.14 |
| PE Ratio | 25.24 |
| Forward PE | 14.89 |
| Dividend | $2.76 (3.48%) |
| Ex-Dividend Date | Mar 21, 2024 |
| Volume | 5,583,196 |
| Open | 80.04 |
| Previous Close | 80.38 |
| Day's Range | 78.78 - 80.35 |
| 52-Week Range | 68.84 - 92.02 |
| Beta | 0.78 |
| Analysts | Buy |
| Price Target | 96.00 (+21.14%) |
| Earnings Date | May 23, 2024 |
About MDT
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accesso... [Read more]
Financial Performance
In 2023, Medtronic's revenue was $31.23 billion, a decrease of -1.45% compared to the previous year's $31.69 billion. Earnings were $3.76 billion, a decrease of -25.42%.
Financial StatementsAnalyst Forecast
According to 13 analysts, the average rating for MDT stock is "Buy." The 12-month stock price forecast is $96.0, which is an increase of 21.14% from the latest price.
News
Americans favor quality over quantity in pursuit of longevity
According to a new survey from Medtronic and Morning Consult, nearly two-thirds of U.S. adults say they'd opt for a shorter, healthier life than a longer one with health issues DUBLIN , April 17, 2024...
Cosmo and Medtronic Unveil the Future of AI in GI: Genius Summit 2024 Reveals Innovations and Collaborations That Advance Endoscopic Care
Dublin, Ireland--(Newsfile Corp. - April 12, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) announces that Medtronic plc (NYSE: MDT), a global leader in healthcare technology, pre...
This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?
A new exchange-traded fund needs an edge to attract investors. This might be its industry focus — a tall order in a crowded market with ETFs covering just about any industry you can imagine.
Medtronic unveils the future of AI in GI: Genius Summit 2024 reveals innovations and collaborations that advance endoscopic care
AI-driven solutions and strategic alliances showcase Medtronic's promise to enhance the efficiency and effectiveness of endoscopy DUBLIN , April 10, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a g...
ModMed & Medtronic Collaborate to Drive Efficiencies in Documenting Colonoscopies Using AI
BOCA RATON, Fla.--(BUSINESS WIRE)--ModMed® announced it will collaborate with Medtronic to enhance documentation of polyp detection by using AI capabilities of the GI Genius system.
BioCT Welcomes Mike Stow of Medtronic to Its Board of Directors
NEW HAVEN, Conn.--(BUSINESS WIRE)--BioCT, Connecticut's life sciences trade association, is thrilled to announce the appointment of Mike Stow, Vice President of Global Marketing for Robotic Surgical T...
OM1 and Medtronic Partner on Propel Study to Assess Long-term Outcomes for Patients With Chronic Rhinosinusitis
BOSTON--(BUSINESS WIRE)--OM1, the leading AI and insights-driven technology and data company specializing in personalized medicine, evidence generation, and real-world evidence, today announced result...
The Medtronic Sphere-360™ Pulse Field Ablation (PFA) catheter, a new paradigm in single-shot ablation, demonstrates impressive results in treating paroxysmal atrial fibrillation
EHRA late-breaking data: Results highlight efficacy, safety, and durability of the novel PFA catheter that is fully integrated with Affera™ Mapping and Ablation System DUBLIN and BERLIN , April 8, 202...
SMART trial one-year data demonstrates Medtronic Evolut™ TAVR platform as optimal treatment for severe aortic stenosis in patients with small annulus, which is primarily women
New data from largest head-to-head randomized control TAVR trial demonstrates non-inferior clinical outcomes and superior valve performance for Evolut TAVR compared to Sapien™ at one year DUBLIN and A...
New survey uncovers lack of awareness around heart valve disease and risk factors among women
Despite prevalence of chronic conditions associated with aortic stenosis in women over 65, the majority have never been referred to a cardiologist; Racial disparities may present further opportunities...
Medtronic announces FDA approval of newest-generation Evolut TAVR system for treatment of symptomatic severe aortic stenosis
The Evolut™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access DUBLIN , March 27, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), ...
Viz.ai and Medtronic Collaborate to Improve Post-Acute Stroke Patient Care in the United States
SAN FRANCISCO--(BUSINESS WIRE)-- #ai--Viz.ai, Inc., the leader in AI-powered disease detection and intelligent care coordination, today announced a strategic collaboration with Medtronic to improve th...
U.S. Patent Office rejects Axonics' latest challenge to Medtronic patents
Medtronic moves for patent infringement litigation to resume DUBLIN , March 21, 2024 /PRNewswire/ -- Medtronic (NYSE:MDT), the global leader in healthcare technology, today announced that the Patent ...
New real-world data shows MiniMed™ 780G system sustains strong global performance, exceeding international targets for diabetes management
New data presented at ATTD demonstrates the system's ability to help individuals with type 1 diabetes exceed international targets on outcome measures DUBLIN and FLORENCE, Italy , March 9, 2024 /PRNew...
Medtronic announces cash dividend for fourth quarter of fiscal year 2024
Board authorizes $5 billion for share repurchases DUBLIN , March 7, 2024 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE: MDT) on Thursday, March 7, 2024, approved the company's cash di...
Medtronic EVP & CFO Karen Parkhill to participate in the Barclays healthcare conference
DUBLIN , March 5, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 26th annual Barclays global healthcare conference ...
What's Next For Medtronic Stock After An Upbeat Q3?
Medtronic MDT (NYSE: MDT) recently reported its Q3 fiscal 2024 results (fiscal ends in April), with revenues and earnings beating the street estimates. The company reported revenue of $8.1 billion and...
Medtronic files ITC action against Axonics to stop unauthorized use of Medtronic innovations
DUBLIN , Feb. 29, 2024 /PRNewswire/ -- Medtronic (NYSE:MDT), the global leader in healthcare technology, today announced it filed a complaint with the U.S. International Trade Commission (ITC), along ...
Medtronic Nixes Spinoff Plans For Monitoring And Respiratory Units
Medtronic's choice to retain its PMRI Business is mainly driven by the improved performance of its Patient Monitoring segment in recent times, is a result of a comprehensive evaluation of its portfoli...
Medtronic Beats Estimates and Boosts Outlook on Heart, Diabetes Device Sales
Shares of Medtronic PLC (MDT) gained Tuesday after the medical technology firm posted better-than-expected results and raised its guidance on increased demand for its heart and diabetes devices.
Medtronic CEO on earnings: Back to growth in China after challenging few years
Geoff Martha, Medtronic CEO, joins 'Money Movers' to discuss the company's quarterly earnings results, Medtronic's business in China, and how Martha is thinking about the company's portfolio.
Medtronic Stock Jumps. Medical Device Maker Tops Earnings and Raises Forecast.
Medtronic reported adjusted per-share earnings of $1.30, beating Wall Street's call for $1.26, according to FactSet.
Medtronic beats profit estimates on strong demand for heart devices
Medtronic beat Wall Street estimates for third-quarter profit on Tuesday, aided by strong demand for its heart and diabetes devices.
Medtronic reports third quarter fiscal 2024 financial results
Delivers on commitments with strong growth in Core Spine, Cardiac Surgery, Structural Heart, Cardiac Pacing, and across many international markets; Diabetes increases double digits as U.S. business re...
Medtronic to announce financial results for its third quarter of fiscal year 2024
DUBLIN , Feb. 6, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its third quarter of fiscal year 202...